Serum Institute seeks indemnification and believes that regulations should be same for everyone
June 3, 2021
130
1
0.77%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Mirror Now Episodes Around June 3, 2021
See what was published immediately before and after this episode.
3:25Now PlayingSerum Institute seeks indemnification and believes that regulations should be same for everyone
YouTube Description
as posted by the channelThe Serum Institute of India, whose Covid vaccination Covishield is being given to Indian residents, has requested legal protection against liability. This comes after sources close to the ongoing talks between Pfizer and Moderna and the Indian government told India Today TV that giving indemnification to these US-based pharmaceutical behemoths will not be a problem at this point. Pfizer-BioNTech was in talks with the Indian government last year and had filed to the regulators for an emergency use authorization (EUA) for its vaccine. Pfizer, on the other hand, insisted on waiving the bridging studies and lobbied for legal protection through indemnity.
SUBSCRIBE NOW for more such videos ►
For More Updates ►
Like us on Facebook ►
Follow us on Twitter ►
Follow us on Instagram ►
Links & Promotions
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.